Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation

P. Cannon, Christopher; L. Bhatt, Deepak; Oldgren, Jonas; Y.H. Lip, Gregory; G. Ellis, Stephen; Kimura, Takeshi; Mæng, Michael; Merkely, Béla; Zeymer, Uwe; Gropper, Savion; Nordaby, Matias; Kleine, Eva; Harper, Ruth; Manassie, Jenny; L. Januzzi, James; M. ten Berg, Jurriën; Gabríel Steg, Philippe; H. Hohnloser, Stefan

doi:10.1056/nejmoa1708454

Public

Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation

Published in New England Journal of Medicine • Aug 27, 2017

Authors:

Christopher P. Cannon

Deepak L. Bhatt

Jonas Oldgren

Abstract

BACKGROUND: Triple antithrombotic therapy with warfarin plus two antiplatelet agents is the standard of care after percutaneous coronary intervention (PCI) for patients with atrial fibrillation, but this therapy is associated with a high risk of bleeding. METHODS: inhibitor (clopidogrel or ticagrelo...

Subject

Dabigatran

Atrial fibrillation

Antithrombotic

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!